With the deepening of the researches on uric acid, especially in the study of metabolic
diseases, uric acid has been found to be closely related to obesity, metabolic syndrome …

Abstract Purpose of Review Compared to adult-onset type 2 diabetes (T2D), youth with T2D
have a more aggressive phenotype with greater insulin resistance (IR), more rapid β cell …

Focal segmental glomerulosclerosis (FSGS) is an important cause of nondiabetic chronic
kidney disease (CKD). Sodium-glucose cotransporter 2 inhibition (SGLT2i) therapy …

OBJECTIVE In people with type 2 diabetes, sodium–glucose cotransporter 2 inhibitors
(SGLT2i) reduce cardiovascular risk and progression of diabetic kidney disease. Our aim …

Background: While elevated serum uric acid level (SUA) is a recognized risk factor for
chronic kidney disease, it remains unclear whether change in SUA is independently …

Introduction: Using data from the ertugliflozin cardiovascular outcomes trial in patients with
type 2 diabetes mellitus (VERTIS CV; NCT01986881), associations between the initial …

Over the past 30 years there have been many complementary therapies developed to
achieve glycemic control and have an impact on cardiovascular outcomes, as well as …

Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease. A
major challenge in preventing DKD is the difficulty in identifying high-risk patients at a …

Abstract Background/Aim To assess the correlation between serum uric acid (UA) level and
diabetic kidney disease (DKD) in Type 1 diabetes (T1DM) patients in Anhui, China. Methods …

Higher plasma uric acid (PUA) levels are associated with lower glomerular filtration rate
(GFR) and higher blood pressure (BP) in patients with type 1 diabetes (T1D). Our aim was to …